Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Number of holders
-
269
-
Total 13F shares, excl. options
-
84,732,406
-
Shares change
-
+1,742,153
-
Total reported value, excl. options
-
$2,752,093,285
-
Value change
-
+$61,774,959
-
Put/Call ratio
-
118%
-
Number of buys
-
126
-
Number of sells
-
118
-
Price
-
$32.48
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2023
As of 31 Dec 2023 CORCEPT THERAPEUTICS INC - Common Stock (CORT) had 318 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 84,732,406 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, STATE STREET CORP, Novo Holdings A/S, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and Boston Trust Walden Corp.
This table shows 318 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.